Charles Schwab Investment Management Inc Celularity Inc Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.42 - $0.81 $61,753 - $119,095	-147,031 Reduced 84.31%	27,363 $14,000
Q4 2022 Feb 13, 2023	SELL	$1.08 - $2.35 $1,383 - $3,010	-1,281 Reduced 0.73%	174,394 $224,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $60,820 - $609,619	141,443 Added 413.19%	175,675 $406,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $96,191 - $441,935	34,232 New	34,232 $117,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $313M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.